Skip to main content
. 2021 Sep 27;4(9):e2126126. doi: 10.1001/jamanetworkopen.2021.26126

Table 2. Characteristics of Participants With Type 1 Diabetes by Insulin Pump Use.

Characteristic Use of insulin pump, No./total No. (%) P valuea
No Yes
Total participants, No. 658 558 NA
Age at screening, mean (SD), y 15.9 (3.7) 15.1 (3.9) <.001
Age at diabetes diagnosis, mean (SD), y 8.3 (3.9) 7.1 (3.6) <.001
Duration of diabetes, mean (SD), y 7.7 (4.4) 8.1 (4.0) .14
Sex
Female 316/658 (48.0) 299/558 (53.6) .05
Male 342/658 (52.0) 259/558 (46.4)
Race and ethnicity
Hispanic 187/658 (28.4) 94/558 (16.8) <.001
Non-Hispanic Black or African American 178/658 (27.1) 66/558 (11.8)
Non-Hispanic White 250/658 (38.0) 361/558 (64.7)
Otherb 43/658 (6.5) 37/558 (6.6)
Insurance
Private/commercial 351/628 (55.9) 404/550 (73.5) <.001
Public/Medicaid 277/628 (44.1) 146/550 (26.5)
BMI percentile, mean (SD)c 72.2 (25.9) 70.5 (25.1) .27
Diabetic retinopathy diagnosis 33/658 (5.0) 10/558 (1.8) .002
Use of continuous glucose monitor 116/658 (17.6) 308/558 (55.2) <.001
HbA1c, level
Mean (SD), % 10.0 (2.1) 8.7 (1.5) <.001
Last measurement, mean (SD), % 10.0 (2.3) 8.7 (1.6) <.001
Ever >8% 591/658 (89.8) 438/558 (78.5) <.001
Endocrine appointments within past 12 mo, mean (SD), No.d 1.9 (1.5) 2.5 (1.4) <.001
Diabetic ketoacidosis admissions within past 12 mo, mean (SD), No.d 0.09 (0.37) 0.04 (0.22) .01

Abbreviations: BMI, body mass index; HbA1c, hemoglobin A1c; NA, not applicable.

a

P values were derived from χ2 test for categorical variables and t test for continuous variables.

b

Includes patients who were Asian (n = 50) and those who did not specify race or ethnicity, specified other race or ethnicity, or for whom data on race or ethnicity were not available (n = 51).

c

The BMI percentiles were obtained by plotting values on the Centers for Disease Control and Prevention’s BMI-for-Age charts for boys and girls.31

d

Data only available for the 1332 patients at Baylor College of Medicine/Texas Children’s Hospital.